Continuous Glucose Monitor in Adult Diabetic Ketoacidosis

Diabetic ketoacidosis (DKA) is a potentially fatal hyperglycemic emergency that requires rapid recognition and treatment. The incidence of this complication has increased over the past 2 decades. In the United States, for example, the rate of DKA in patients with type 1 diabetes increased from 32.04 cases per 10,000 admissions in 2003 to 61.6 cases per 10,000 admissions in 2017.1 The management of DKA involves IV fluid administration, insulin therapy, and electrolyte correction.2 Although the cornerstone of DKA treatment has remained the same for many decades, the method of glucose monitoring has been a subject of debate.